Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 405-800-7 | CAS number: 27955-94-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study in accordance with relevant guideline; selected as the key study because the information provided for the hazard endpoint is sufficient for the purpose of classification and labelling and/or risk assessment.
Data source
Reference
- Reference Type:
- other: reference to body responsible for the test
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- Remarks:
- Study was conducted according to guideline in effect at time of study.
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- 4,4',4''-(ethan-1,1,1-triyl)triphenol
- EC Number:
- 405-800-7
- EC Name:
- 4,4',4''-(ethan-1,1,1-triyl)triphenol
- Cas Number:
- 27955-94-8
- Molecular formula:
- C20H18O3
- IUPAC Name:
- 4,4',4''-(ethan-1,1,1-triyl)triphenol
- Details on test material:
- - Purity: 99%
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Age at study initiation: Not reported.
- Weight at study initiation: 459-546 g
- Housing: Suspended cages with wire mesh floors.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 19 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21
- Humidity (%): 30-70%
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: Intradermal injection vehicle: 5% acetone; Topical application, both induction and challenge: acetone
- Concentration / amount:
- Concentration of test material and vehicle used at induction:
a) Intradermal: 0.5% in 5% acetone in Alembicol D
b) Topical: 80 % in acetone
Concentration of test material and vehicle used for each challenge:
a) 80 % and 40 % in acetone, topically
Challengeopen allclose all
- Route:
- epicutaneous, semiocclusive
- Vehicle:
- other: Intradermal injection vehicle: 5% acetone; Topical application, both induction and challenge: acetone
- Concentration / amount:
- Concentration of test material and vehicle used at induction:
a) Intradermal: 0.5% in 5% acetone in Alembicol D
b) Topical: 80 % in acetone
Concentration of test material and vehicle used for each challenge:
a) 80 % and 40 % in acetone, topically
- No. of animals per dose:
- Number of animals in test group: 20
Number of animals in negative control group: 10 - Details on study design:
- RANGE FINDING TESTS: The intradermal and topical irritancy of a range of dilutions of the test substance was investigated to identify irritant concentrations suitable for the induction phase of the main study and non-irritant concentrations by the topical route for the challenge phase. A concentration of 0.5% was chosen for the intradermal injection as necrosis occurred at the injection site at all higher concentrations. There was no significant irritation at any concentration tested by the topical route. The maximum concentration chosen for topical application was 80% because this concentration of the test substance was the highest that could be prepared within acetone.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: One exposure by intradermal injection and one by topical application
- Exposure period: 1 week after the injections, the topical dose was applied and left in place for 48 hours
- Test groups: One group of 20 animals.
- Control group: One group of 10 animals.
- Site: Interscapular area
- Frequency of applications: Once by injection and once topically to the same area.
- Duration: Topical application dressing was left in place for 48 hours.
- Concentrations: 0.5% by intradermal injection; 80% by topical application.
B. CHALLENGE EXPOSURE
- No. of exposures: One
- Day(s) of challenge: One
- Exposure period: 24 hours
- Test groups: One group of 20 animals were used. Each animal was challenged at two concentrations.
- Control group: One group of 10 animals.
- Site: Area on the left flank.
- Concentrations: 40% and 80%
- Evaluation (hr after challenge): 24, 48, and 72 hours after removal of the patches. - Challenge controls:
- The sensitivity of the guinea-pig strain used was checked periodically. A check using apostive control substance was completed.
- Positive control substance(s):
- yes
- Remarks:
- Formalin
Study design: in vivo (LLNA)
- Positive control substance(s):
- other: Formalin
- Statistics:
- No analysis reported.
Results and discussion
- Positive control results:
- The positive control study (dated: February 10, 1990), induction with 0.1% intradermal injection and 10% topical application followed by topical challenge with 5 and 1% formalin concentrations resulted in a positive result in 10/10 female guinea-pigs.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 80 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 80 %. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 40 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 40 %. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 80 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 80 %. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 40 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 40 %. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 80 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 80 %. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 40 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 40 %. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 80 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 80 %. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 40 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 40 %. No with. + reactions: 0.0. Total no. in groups: 10.0.
Any other information on results incl. tables
Evidence of sensitisation of each challenge concentration: None.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- The study and the conclusions which are drawn from it fulfil the quality criteria (validity, reliability, repeatability). The test substance did not produce any contact sensitivity during the observation in any test organism.
- Executive summary:
The study assessed the skin sensitisation potential of the test substance. Twenty female guinea-pigs were given induction doses by intradermal injection of 0.5%w/w in 5% acetone in Alembicol D and 0.5% w/w in a 50:50 mixture of Freund's complete adjuvant and 5% acetone in Alembicol D. Test organisms were also given an injection of Freund's complete adjuvant diluted with equal volume of water into the same area at the same time. The area was clipped and shaved one week after exposure. Topical application of 80% w/w test substance in acetone was placed on the same area under a semiocclusive dressing for 48 hours. Two weeks later, the test organisms were challenged topically using 80% and 40% concentrations of test substance in acetone. The test substance was left in place for 24 hours. Challenge sites were evaluated at 24, 48, and 72 hours after removal. A vehicle control group of 10 female guinea-pigs was given the same treatments with acetone vehicle.
Reactions were scored on a scale from 0 to 4 for erythema, eschar formation and oedema formation. All test sites were scored 0 for both the test and control animals. The test substance did not produce evidence of contact hypersensitivity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
